SCHEMBL16626439

SCHEMBL16626439

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3ccc(OC(F)(F)F)cc3OC)ccc12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NAMPT P43490 4/20 0.38
HTR6 P50406 4/20 0.37
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
ABL1 P00519 1/20 0.36
CNR2 P34972 2/20 0.36
CNR1 P21554 1/20 0.36
KDR P35968 1/20 0.35
SLC40A1 Q9NP59 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
P2RX7 Q99572 1/20 0.34
TSHR P16473 1/20 0.34
ALPL P05186 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619117 0.99 LMNA (0.38) LMNAHTTSMN1; SMN2NAMPTHTR6
SCHEMBL16626427 0.94 HTR6 (0.40) LMNAHTTSMN1; SMN2NAMPTHTR6
Hydrochloric Acid SCHEMBL16618642 0.93 HTR6 (0.40) LMNAHTTSMN1; SMN2NAMPTHTR6
SCHEMBL17971524 0.92 HTR6 (0.43) SMN1; SMN2NAMPTHTR6CHRNB4CHRNA3
SCHEMBL16626442 0.91 LMNA (0.38) LMNAHTTSMN1; SMN2NAMPTHTR6
SCHEMBL16626430 0.91 LMNA (0.38) LMNAHTTSMN1; SMN2NAMPTHTR6
Hydrochloric Acid SCHEMBL16619106 0.90 LMNA (0.38) LMNAHTTSMN1; SMN2NAMPTHTR6
SCHEMBL16626677 0.90 NAMPT (0.39) LMNAHTTSMN1; SMN2NAMPTHTR6
Hydrochloric Acid SCHEMBL16618657 0.90 LMNA (0.38) LMNAHTTSMN1; SMN2NAMPTHTR6
SCHEMBL16626724 0.90 FBP1 (0.40) HTR6PPARGPPARDPPARACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI LMNA 2432/4885HTT 2200/4885SMN1; SMN2 2343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.